Disclosure Panels Details Page
Breast Cancer Risk Reduction Panel - Disclosures as of 08/14/2020
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Gretchen Ahrendt MD | None | None | None | None | ✔ |
| Banu Arun MD | None | None | None | None | ✔ |
| Mary Anne Bergman | None | None | None | None | ✔ |
| Therese Bevers MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Joshua Cohen MD, FACOG, FACS | None | None | None | None | ✔ |
| Graham Colditz MD, DrPH, FAFPHM | Centine Corp , St Louis Grailbio |
None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Shipra Gandhi MD | Athenex Bristol Myers Squibb Roswell Park |
None | None | None | ✔ |
| Mary Gemignani MD | None | None | None | None | ✔ |
| Heidi Goodwin APRN, CNP | None | None | None | None | ✔ |
| William Gradishar MD | Abbott Laboratories Eli Lilly and Company Genentech, Inc. Immunomedics, Inc. Seattle Genetics, Inc. |
None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Laura Hanisch PsyD | None | None | None | None | - |
| Shelley Hwang MD, MPH | None | None | None | None | ✔ |
| Lisa Jacobs MD | None | None | None | None | ✔ |
| Judith Jordan BS | None | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Tari King MD | None | None | Genomic Health, Inc. | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| Allison Kurian MD, MSc | None | None | None | None | - |
| Sayeh Lavasani MD, MSc, FRCPC | None | None | PUMA Oncology Seattle Genetics, Inc. |
None | ✔ |
| Loretta Loftus MD, MBA | None | Greenberg, Traurig Law Firm Expert Witness Tyme Development Committee United States Department of Justice Expert Witness |
None | Amgen Inc. |Eli Lilly and Company|Gilead Sciences, Inc.|Johnson & Johnson|Pfizer Inc. | ✔ |
| Daniel Lui PharmD, BCPPS | None | None | Brand Institute Inc MedPanel MNOW (Sermo) Reckner |
None | - |
| Sofia Merajver MD, PhD | Founder and equity interest in InheRET, Inc | None | None | Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. | ✔ |
| Ingrid Meszoely MD | None | None | None | None | ✔ |
| Elias Obeid MD, MPH | NA | NA | NA | NA | - |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Catherine Parker MD | None | None | None | None | - |
| Frances Pritchard MD | None | None | None | None | - |
| Sandhya Pruthi MD | None | None | None | None | ✔ |
| Leslie Ray PharmD | None | None | None | None | - |
| Sagar Sardesai MD, MPH | None | None | Biotheranostics Immunomedics, Inc. Novartis Pharmaceuticals Corporation |
None | ✔ |
| Payal Shah MD | None | None | None | None | ✔ |
| Michelle Specht MD, FACS | None | None | None | None | ✔ |
| Pavan Kumar Tandra MD | None | None | None | None | ✔ |
| Anne Wallace MD, FACS | None | None | None | None | ✔ |
| John Ward MD | None | Myriad Genetic Laboratories, Inc. | None | None | ✔ |
| Lee Wilke MD, FACS | None | None | None | Elucent Medical | ✔ |
| Rachel Yung MD | None | None | None | None | ✔ |